Multivariate regression analysis revealed that the vWF activity-antigen ratio was significantly reduced in those who did not use HMG-CoA reductase inhibitors, with DM, and with higher hemoglobin levels. The gene discussed is HMGCR; the disease is diabetes mellitus.